钙或维生素D补充与社区居住老年人骨折发生率的关系:系统综述与Meta分析
该Meta分析纳入33项随机临床试验、共51145名社区居住的50岁以上老年人,比较补充钙、维生素D或两者联合与安慰剂或不治疗对骨折发生率的影响。主要终点髋部骨折方面,钙(RR 1.53,95%CI 0.97-2.42)、维生素D(RR 1.21,95%CI 0.99-1.47)及联合补充(RR 1.09,95%CI 0.85-1.39)与对照相比均无显著关联。非椎体、椎体和总骨折发生率亦无显著关联。亚组分析显示,无论钙或维生素D剂量、性别、骨折史、膳食钙摄入量和基线血清25-羟基维生素D浓度如何,结果基本一致。作者结论认为,这些发现不支持在社区居住的老年人中常规使用这些补充剂。
要点
- 33项RCT、51145名社区居住50岁以上老年人:钙、维生素D或联合补充与安慰剂/不治疗相比,髋部骨折风险均无显著降低(钙RR 1.53,95%CI 0.97-2.42;维生素D RR 1.21,95%CI 0.99-1.47;联合RR 1.09,95%CI 0.85-1.39)。
- 非椎体骨折、椎体骨折和总骨折发生率方面,钙、维生素D或联合补充与对照相比均无显著关联。
- 亚组分析显示,无论钙或维生素D剂量、性别、骨折史、膳食钙摄入量和基线血清25-羟基维生素D浓度如何,结果基本一致。
- 作者结论:这些发现不支持在社区居住的老年人中常规使用钙、维生素D或联合补充剂来预防骨折。
适用人群与场景
- 纳入标准:社区居住的50岁以上成年人,比较钙、维生素D或联合补充与安慰剂或不治疗的随机临床试验。
研究设计与关键结果
- 研究类型:系统综述与Meta分析,纳入33项随机临床试验,共51145名社区居住的50岁以上参与者。
- 主要终点髋部骨折:钙 vs 安慰剂/不治疗 RR 1.53(95%CI 0.97-2.42),ARD 0.01(95%CI 0.00-0.01);维生素D vs 安慰剂/不治疗 RR 1.21(95%CI 0.99-1.47),ARD 0.00(95%CI -0.00-0.01);联合补充 vs 安慰剂/不治疗 RR 1.09(95%CI 0.85-1.39),ARD 0.00(95%CI -0.00-0.00),均无显著关联。
- 次要终点:钙、维生素D或联合补充与非椎体骨折、椎体骨折和总骨折发生率之间均无显著关联。
- 亚组分析:无论钙或维生素D剂量、性别、骨折史、膳食钙摄入量和基线血清25-羟基维生素D浓度如何,结果基本一致。
证据类型、等级与局限
- 证据类型:系统综述与随机临床试验Meta分析。
- 检索数据库:PubMed、Cochrane图书馆和EMBASE,从建库至2016年12月24日;另检索2012年7月16日至2017年7月16日新发表的随机试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,这些发现不支持在社区居住的老年人中常规使用钙、维生素D或联合补充剂来预防骨折。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The increased social and economic burdens for osteoporosis-related fractures worldwide make the prevention of such injuries a major public health goal. Previous studies have reached mixed conclusions regarding the association between calcium, vitamin D, or combined calcium and vitamin D supplements and fracture incidence in older adults.
OBJECTIVE: To investigate whether calcium, vitamin D, or combined calcium and vitamin D supplements are associated with a lower fracture incidence in community-dwelling older adults.
DATA SOURCES: The PubMed, Cochrane library, and EMBASE databases were systematically searched from the inception dates to December 24, 2016, using the keywords calcium, vitamin D, and fracture to identify systematic reviews or meta-analyses. The primary randomized clinical trials included in systematic reviews or meta-analyses were identified, and an additional search for recently published randomized trials was performed from July 16, 2012, to July 16, 2017.
STUDY SELECTION: Randomized clinical trials comparing calcium, vitamin D, or combined calcium and vitamin D supplements with a placebo or no treatment for fracture incidence in community-dwelling adults older than 50 years.
DATA EXTRACTION AND SYNTHESIS: Two independent reviewers performed the data extraction and assessed study quality. A meta-analysis was performed to calculate risk ratios (RRs), absolute risk differences (ARDs), and 95% CIs using random-effects models.
MAIN OUTCOMES AND MEASURES: Hip fracture was defined as the primary outcome. Secondary outcomes were nonvertebral fracture, vertebral fracture, and total fracture.
RESULTS: A total of 33 randomized trials involving 51 145 participants fulfilled the inclusion criteria. There was no significant association of calcium or vitamin D with risk of hip fracture compared with placebo or no treatment (calcium: RR, 1.53 [95% CI, 0.97 to 2.42]; ARD, 0.01 [95% CI, 0.00 to 0.01]; vitamin D: RR, 1.21 [95% CI, 0.99 to 1.47]; ARD, 0.00 [95% CI, -0.00 to 0.01]. There was no significant association of combined calcium and vitamin D with hip fracture compared with placebo or no treatment (RR, 1.09 [95% CI, 0.85 to 1.39]; ARD, 0.00 [95% CI, -0.00 to 0.00]). No significant associations were found between calcium, vitamin D, or combined calcium and vitamin D supplements and the incidence of nonvertebral, vertebral, or total fractures. Subgroup analyses showed that these results were generally consistent regardless of the calcium or vitamin D dose, sex, fracture history, dietary calcium intake, and baseline serum 25-hydroxyvitamin D concentration.
CONCLUSIONS AND RELEVANCE: In this meta-analysis of randomized clinical trials, the use of supplements that included calcium, vitamin D, or both compared with placebo or no treatment was not associated with a lower risk of fractures among community-dwelling older adults. These findings do not support the routine use of these supplements in community-dwelling older people.
参考来源
- Zhao JG, Zeng XT, Wang J, et al. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-analysis. JAMA. 2017. PMID: 29279934. doi:10.1001/jama.2017.19344
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。